Crane NXT raised the midpoint of full-year adjusted EPS guidance while narrowing the range to $4.32 to $4.42; third-quarter sales were $497 million, up 12% year over year, and adjusted free cash flow was $98 million, up 15%.
CXT · Crane NXT, Co.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Crane NXT reported third-quarter 2026 net sales of $497.1 million, up 11.7%, while operating profit fell 19.8% to $65.7 million.
Crane NXT posted sales of $497 million, up 12%, and Adjusted EPS of $1.28. Full-year Adjusted EPS guidance was raised to $4.32 to $4.42 from $4.22 to $4.42, while sales growth guidance was cut to ~14% from +15% to +17%.
Crane NXT appointed Jeong H. Kim to its Board of Directors effective October 29, 2026, for a term expiring at the next Annual Meeting and until his successor is elected and qualified; his compensation will be prorated.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Nov 5, 2026TL;DR. Crane NXT grew consolidated sales and adjusted EBITDA, raised and narrowed full-year adjusted EPS guidance, generated strong free cash flow, delivered SAT growth and margin expansion, and secured long-term customer wins. The outlook was tempered by lower total and DTT sales-growth guidance, weak DTT organic growth, acquisition-driven margin dilution, and continued softness in CPI vending and hardware.
- + Long-term commercial awards strengthened revenue visibility for 2027 and beyond.
- + Adjusted free cash flow rose 15% year over year to $98 million, with approximately 132% conversion.
- + SAT backlog increased 8% to approximately $482 million, with orders being booked into the second half of 2028.
- + Antares Vision is on track to achieve its targeted 2026 adjusted EBITDA contribution as operating synergies emerge.
- + Full-year adjusted EPS guidance was raised at the midpoint and narrowed to $4.32-$4.42.
- + Third-quarter sales increased 12% year over year to $497 million, while adjusted EBITDA increased 4% to $127 million.
- − DTT organic sales declined 5%, while Antares Vision sales were affected by project timing and the life sciences end market.
- − CPI hardware was the largest headwind, with several big-box retailers postponing previously announced upgrade and refresh programs.
- − Company adjusted EBITDA margin declined 190 basis points to 25.6% because of Antares Vision acquisition dilution.
- − DTT adjusted EBITDA margin declined 430 basis points because of Antares Vision dilution.
- − GAAP net income declined 24% year over year to $38.4 million.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Acquisitions non-GAAP | $74.6M | Three Months Ended June 30, 2026 | — |
| Adjusted EBITDA non-GAAP | $190.2M | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 23.4% | Q2 2026 | — |
| Adjusted free cash flow non-GAAP | $60.5M | Six Months Ended June 30, 2026 | — |
| Adjusted free cash flow conversion non-GAAP | 61.4% | Six Months Ended June 30, 2026 | — |
| Adjusted net income non-GAAP | $98.6M | Six Months Ended June 30, 2026 | — |
| Adjusted net income per share non-GAAP | $1.7 | Six Months Ended June 30, 2026 | — |
| DTT Adjusted EBITDA non-GAAP | $70.4M | Q2 2026 | — |
| DTT Adjusted EBITDA margin non-GAAP | 26.4% | Q2 2026 | — |
| DTT organic sales growth non-GAAP | -3.4% | Q2 2026 | — |
| Free cash flow non-GAAP | $49.3M | Six Months Ended June 30, 2026 | — |
| Net debt non-GAAP | $1.25B | June 30, 2026 | — |
| Order Backlog - Detection and Traceability Technologies | $257.4M | June 30, 2026 | — |
| Order Backlog - Security and Authentication Technologies | $498.1M | June 30, 2026 | — |
| Organic sales non-GAAP | $11.3M | Three Months Ended June 30, 2026 | — |
| Organic sales growth non-GAAP | 2.8% | Q2 2026 | — |
| SAT Adjusted EBITDA non-GAAP | $58.8M | Q2 2026 | — |
| SAT Adjusted EBITDA margin non-GAAP | 25.9% | Q2 2026 | — |
| SAT organic sales growth non-GAAP | 9.6% | Q2 2026 | — |
| Total backlog | $755.5M | June 30, 2026 | — |
| TTM Adjusted EBITDA non-GAAP | $459.4M | June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Business Equipment & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CXT
this stock
Crane NXT, Co.
|
$3.19B | +17.7% | -1.0% | 25.2 | 15.7% |
|
LYTS
Lsi Industries Inc
|
$561.69M | -17.8% | +22.1% | 23.9 | 9.4% |
|
ACCO
ACCO BRANDS Corp
|
$517.11M | +50.1% | -8.5% | 8.0 | 6.8% |
|
ACTG
Acacia Research Corp
|
$394.58M | +9.4% | -59.7% | — | 1.6% |
|
XRX
Xerox Holdings Corp
|
$117.20M | -62.9% | +12.9% | — | 31.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CXT | -4.5% | -1.4% | +42.6% | -5.5% | +17.7% |
| SPY | -3.9% | -5.6% | -3.5% | -3.4% | +7.1% |
| vs SPY | -0.6% | +4.1% | +46.1% | -2.1% | +10.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.